335 related articles for article (PubMed ID: 11323475)
21. [99mTc-MIBI characterization of breast microcalcifications. Correlations with scintigraphic and histopathologic findings].
Vanoli C; Antronaco R; Giovanella L; Ceriani L; Sessa F; Fugazzola C
Radiol Med; 1999; 98(1-2):19-25. PubMed ID: 10566292
[TBL] [Abstract][Full Text] [Related]
22. Nonpalpable, probably benign lesions: role of follow-up mammography.
Varas X; Leborgne F; Leborgne JH
Radiology; 1992 Aug; 184(2):409-14. PubMed ID: 1620838
[TBL] [Abstract][Full Text] [Related]
23. Breast US in patients who had microcalcifications with low concern of malignancy on screening mammography.
Kang SS; Ko EY; Han BK; Shin JH
Eur J Radiol; 2008 Aug; 67(2):285-291. PubMed ID: 17703906
[TBL] [Abstract][Full Text] [Related]
24. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases.
Sickles EA
Radiology; 1991 May; 179(2):463-8. PubMed ID: 2014293
[TBL] [Abstract][Full Text] [Related]
25. Consensus review: A method of assessment of calcifications that appropriately undergo a six-month follow-up.
Kuzmiak CM; Dancel R; Pisano E; Zeng D; Cole E; Koomen MA; McLelland R
Acad Radiol; 2006 May; 13(5):621-9. PubMed ID: 16627203
[TBL] [Abstract][Full Text] [Related]
26. Nonpalpable, well-defined, probably benign breast nodule: management by fine-needle aspiration biopsy and long-interval follow-up mammography.
Apesteguía L; Pina L; Inchusta M; Mellado M; Franquet T; De Miguel C; López-Cousillas A; Repáraz B
Eur Radiol; 1997; 7(8):1235-9. PubMed ID: 9377508
[TBL] [Abstract][Full Text] [Related]
27. Short-term follow-up of palpable breast lesions with benign imaging features: evaluation of 375 lesions in 320 women.
Harvey JA; Nicholson BT; Lorusso AP; Cohen MA; Bovbjerg VE
AJR Am J Roentgenol; 2009 Dec; 193(6):1723-30. PubMed ID: 19933671
[TBL] [Abstract][Full Text] [Related]
28. Probably benign breast masses at US: is follow-up an acceptable alternative to biopsy?
Graf O; Helbich TH; Hopf G; Graf C; Sickles EA
Radiology; 2007 Jul; 244(1):87-93. PubMed ID: 17581897
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of abnormal mammography results and palpable breast abnormalities.
Kerlikowske K; Smith-Bindman R; Ljung BM; Grady D
Ann Intern Med; 2003 Aug; 139(4):274-84. PubMed ID: 12965983
[TBL] [Abstract][Full Text] [Related]
30. Ultrasonography as adjunct to mammography in the evaluation of breast tumors.
Skaane P
Acta Radiol Suppl; 1999; 420():1-47. PubMed ID: 10693544
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up.
Jackman RJ; Nowels KW; Rodriguez-Soto J; Marzoni FA; Finkelstein SI; Shepard MJ
Radiology; 1999 Mar; 210(3):799-805. PubMed ID: 10207484
[TBL] [Abstract][Full Text] [Related]
32. A prospective comparison of stereotaxic fine-needle aspiration versus stereotaxic core needle biopsy for the diagnosis of mammographic abnormalities.
Symmans WF; Weg N; Gross J; Cangiarella JF; Tata M; Mazzo JA; Waisman J
Cancer; 1999 Mar; 85(5):1119-32. PubMed ID: 10091797
[TBL] [Abstract][Full Text] [Related]
33. Prospective evaluation of the value of combined mammographic and sonographic assessment in patients with palpable abnormalities of the breast.
Shetty MK; Shah YP; Sharman RS
J Ultrasound Med; 2003 Mar; 22(3):263-8; quiz 269-70. PubMed ID: 12636326
[TBL] [Abstract][Full Text] [Related]
34. Management of probably benign breast lesions.
Sickles EA
Radiol Clin North Am; 1995 Nov; 33(6):1123-30. PubMed ID: 7480660
[TBL] [Abstract][Full Text] [Related]
35. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
36. [Ultrasound follow-up of palpable solid, probably benign breast lesions (BI-RADS category III)].
Graf O; Helbich TH; Fuchsjäger MH; Hopf G; Morgun M; Graf C; Mallek R
Rofo; 2004 Sep; 176(9):1251-6. PubMed ID: 15346259
[TBL] [Abstract][Full Text] [Related]
37. Nonpalpable breast cancer: mammographic appearance as predictor of histologic type.
Thurfjell MG; Lindgren A; Thurfjell E
Radiology; 2002 Jan; 222(1):165-70. PubMed ID: 11756721
[TBL] [Abstract][Full Text] [Related]
38. Nonpalpable breast lesions: accuracy of prebiopsy mammographic diagnosis.
Hermann G; Janus C; Schwartz IS; Krivisky B; Bier S; Rabinowitz JG
Radiology; 1987 Nov; 165(2):323-6. PubMed ID: 3659350
[TBL] [Abstract][Full Text] [Related]
39. Revisiting the mammographic follow-up of BI-RADS category 3 lesions.
Varas X; Leborgne JH; Leborgne F; Mezzera J; Jaumandreu S; Leborgne F
AJR Am J Roentgenol; 2002 Sep; 179(3):691-5. PubMed ID: 12185047
[TBL] [Abstract][Full Text] [Related]
40. Histologic work-up of non-palpable breast lesions classified as probably benign at initial mammography and/or ultrasound (BI-RADS category 3).
Gruber R; Jaromi S; Rudas M; Pfarl G; Riedl CC; Flöry D; Graf O; Sickles EA; Helbich TH
Eur J Radiol; 2013 Mar; 82(3):398-403. PubMed ID: 22429299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
